<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Plasmodium falciparum ensures <span id='am-18' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-19' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-21' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-23' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span><span id='am-24' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span>amino acid</span> supply multiple acquisition pathways redundant <br /> proteolytic enzyme systems <br /> Jun Liu*, Eva S. Istvan*, Ilya Y. Gluzman, Julia Gross, Daniel E. Goldberg&#226;&#8364;&#160; <br /> Howard Hughes Medical Institute, Departments Medicine Molecular Microbiology, Washington University School Medicine, 660 South Euclid <br /> Avenue, Box 8230, St. Louis, MO 63110 <br />  <br /> Edited Louis H. Miller, National Institutes Health, Rockville, MD, approved April 24, 2006 (received review March 8, 2006) <br />  <br /> Degradation host hemoglobin human malaria parasite                     strict (13&#226;&#8364;&#8220;15). Knockouts plasmepsins individually Plasmodium falciparum massive metabolic process. role                  combination (plasmepsin IV&#229;&#8230;&#190;I double knockout) parasites degradation plays essential parasite                  slightly impaired growth (5, 16), falcipain-2 <br /> survival established, roles                    knockout shows normal growth (17). effect aspartic <br /> various degradative enzymes clearly defined. report                 protease inhibitors potentiated combined cysteine <br /> P. falciparum grow medium containing single amino acid                  protease inhibitors used falcipain-2 knockout parasites (15, <br /> (isoleucine, amino acid missing human hemoglobin).                 17). evidence suggests overlap medium, growth hemoglobin-degrading enzyme gene                       food vacuole proteolytic families; relative roles <br /> knockout lines (missing falcipain-2 plasmepsins                                                                                  remain unclear. <br /> combination) impaired. Blockade plasmepsins potent <br />                                                                                     cultured P. falciparum parasites able <br /> inhibitor pepstatin minimal effect WT parasite growth <br />                                                                                  grow medium containing isoleucine  amino kills falcipain-2 knockout parasites low concentrations                                                                                  acid lacking human hemoglobin) sole exog- potent falcipain-2, plasmepsin IV triple <br /> knockout parasites. conclude   ) hemoglobin degradation <br />                                                                                  enously supplied amino acid. used medium necessary parasite survival; (ii ) hemoglobin degradation              explore function hemoglobin degradation sufficient supply parasite&#226;&#8364;&#8482;s amino acid requirements;             roles food vacuole plasmepsins falcipains. <br /> (iii ) external amino acid acquisition hemoglobin digestion                                                                                  Results <br /> partially redundant nutrient pathways; (iv) hemoglobin degrada- <br /> tion uses dual protease families overlapping function;                  Amino Acid Requirements Parasite Growth. Divo et al. (4) <br /> (v) hemoglobin-degrading plasmepsins promising drug                      discovered P. falciparum grow short term culture <br /> targets.                                                                         medium containing amino acids (cysteine, glutamate, <br />                                                                                  glutamine, methionine, isoleucine) (5AA). 6 days hemoglobin &#229;&#8230;&#169; malaria &#229;&#8230;&#169; protease                                                  medium, parasitemia 5% rich RPMI medium <br />                                                                                  1640 containing 20 amino acids (5). finding suggested <br />                                                                                  P. falciparum relies exogenous amino acid supplemen- <br /> D     uring intraerythrocytic stage, Plasmodium falciparum  <br />       gests degrades 75% host cell hemoglobin (1). massive catabolic process takes place inside acidic <br />                                                                                  tation growth requirement. minimal growth <br />                                                                                  achieved 5AA likely depend hemoglobin <br /> food vacuole involves pathway proteolytic enzymes (2).                  degradation, amino acid biosynthetic pathways Despite extensive study, purpose hemoglobin degradation                   missing parasite (3, 18) added amino acids relative role different proteases remain unclear.             lacking limited hemoglobin. examine role functions proposed hemoglobin catabolism. Provi-                   amino acids, assessed parasite growth 5AA <br /> sion nutrients parasite energy and&#229;&#8230;&#190;or protein synthesis needs             lacking amino acids separately. Trophozoite- obvious potential role. radioactivity labeled                    stage parasites incubated 25 h assessed devel- <br /> hemoglobin incorporated parasite protein (3).  P.                opmental progression flow cytometry. Parasites incubated <br /> falciparum grows poorly medium lacking seven amino                 5AA progressed schizont stage acids sluggish grown medium containing              reinvaded fresh RBCs, evidenced rise parasitemia amino acids reliant (4, 5). findings suggest           emergence peak corresponding ring-stage parasites (Fig. dependence exogenously supplied amino acids.                      1A). Parasites incubated culture medium amino <br /> strains P. falciparum digest considerably hemoglobin,                acids  AA) stalled development. parasites excrete substantial portion amino acids               amino acid time omitted 5AA, parasites developed <br /> liberated hemoglobin (6). Alternatively, suggested <br />                                                                                  actually grew slightly better 5AA. parasite digests hemoglobin make room itself erythrocyte (6) maintain osmotic balance (7). assump- <br /> tions inherent osmotic hypothesis controversial (8),              Conflict statement: conflicts declared. association volume hemoglobin correlative.              paper submitted directly (Track II) PNAS office. remains unclear parasite degrades hemoglobin.                         Freely available online PNAS open access option. <br />    regard enzymology hemoglobin degradation, <br />                                                                                  Abbreviations: AA, culture medium amino acids; medium, AA supple- families proteases play prominent roles. aspartic                    mented isoleucine sole amino acid; 5AA, culture medium amino <br /> proteases called plasmepsins cysteine proteases called                 acids (cysteine, <span id='am-25' about='obo:IMR_0100119' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-26' property="oboInOwl:id" content="IMR:0100119" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasExactSynonym" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="glutamic acid" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasDbXref" content="KEGG:C00025" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasAlternativeId" content="IMR:0200156" datatype="xsd:string"></span><span id='am-31' property="rdfs:label" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="L-Glutamate" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="L-Glutamate" datatype="xsd:string"></span><span id='am-34' property="rdfs:label" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-35' property="oboInOwl:hasExactSynonym" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>glutamic acid</span>, glutamine, isoleucine, methionine); Triple1, plasmepsins <br /> falcipains food vacuole (9&#226;&#8364;&#8220;12).                 I&#229;&#8230;&#190;IV falcipain-2 triple knockout clone 1; Triple2, plasmepsins I&#229;&#8230;&#190;IV falcipain-2 triple <br /> capable degrading hemoglobin globin biochemical assays                  knockout clone 2; E64, trans-epoxysuccinyl-L-leucylamino(4-guanidine)-butane. <br />  <br /> using recombinant enzyme, order action                      *J.L. E.S  contributed equally work. <br /> unclear (9&#226;&#8364;&#8220;14). Inhibitors aspartic cysteine proteases kill                  correspondence addressed. E-mail: goldberg@borcim.wustl.edu. <br /> parasites culture animal models, specificity               &#194;&#169; 2006 National Academy Sciences USA <br />  <br />  <br />  <br /> 8840 &#226;&#8364;&#8220; 8845 &#229;&#8230;&#169; PNAS &#229;&#8230;&#169; June 6, 2006 &#229;&#8230;&#169; vol. 103 &#229;&#8230;&#169;  23                                                                www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0601876103 <br />  Fig. 1. Amino acid requirements cultured WT parasites.   Flow cytometry starting culture cultures incubated different media 25 h. FITC-H <br /> channel histograms shown. truncated, low fluorescence peaks correspond uninfected RBCs. RBCs infected mature parasites (schizonts) high <br /> fluorescence intensity correspond far-right peaks. RBCs infected younger (ring trophozoite) parasites closer uninfected RBC peak. single amino acid omitted 5AA indicated. AA used control (Lower Right). Parasitemia gates (defined Materials Methods) shown horizontal bars, parasitemias listed underneath bar. starting culture Upper Left, media used listed bar. <br /> (B) Isoleucine dose dependence. Parasites incubated 51 h AA supplemented varying concentrations isoleucine. y axis percent growth <br /> relative RPMI medium 1640. Error bars indicate SD triplicate measurements. (C) Effect 4-thiaisoleucine. Parasites cultured AA <br /> supplemented follows: lane  addition; lane b, 15 &#226;?&#174;M isoleucine; lane c, 15 &#226;?&#174;M isoleucine plus 100 &#226;?&#174;M 4-thiaisoleucine. Gray bars indicate 51-h <br /> incubation; black bars indicate 124-h incubation. Representative experiments repeated times shown. <br />  <br />  <br />  <br /> contrast, omission isoleucine resulted stalled culture                     1640 containing 20 amino acids. Initial experiments similar grown complete absence amino acids.                          using 382 &#226;?&#174;M isoleucine, concentration    determined isoleucine itself sufficient                   RPMI medium 1640  5AA). titration isoleucine support parasite growth. Remarkably, P. falciparum grown                        addition AA showed parasitemia 51 h saturated isoleucine sole exogenous amino acid did better                   86% RPMI medium 1640, isoleucine 5AA, growth nearly rich RPMI medium                      concentrations &#226;&#172;&#381;20 &#226;?&#174;M (Fig. 1B). stimulation growth  <br />  <br />  <br />  <br />                                                                                                    Fig. 2. Creation chromosomal falcipain-2 disruption.   <br />                                                                                                    Schematic falcipain locus chromosome 11. PacI (P) <br />                                                                                                    digestion results fragments 4.0 kb (falcipain-2, FP2)                                                                                                    16.8 kb (falcipain-2&#226;&#172;&#732;, FP2&#226;&#172;&#732;). FP3, falcipain-3. (B) Schematic                                                                                                    falcipain-2 knockout plasmid. FP2&#226;&#8364;&#8220;5&#226;&#172;&#732; 590-bp fragment <br />                                                                                                    homologous 5&#226;&#172;&#732; coding region falcipain-2 gene. <br />                                                                                                    FP2&#226;&#8364;&#8220;3&#226;&#172;&#732; 605-bp fragment homologous 3&#226;&#172;&#732; coding <br />                                                                                                    region falcipain-2 gene. 7.9-kb plasmid PacI <br />                                                                                                    site. BSD, blasticidin S-deaminase. (C ) Schematic falci- <br />                                                                                                    pain-2 knockout resulting double crossover. PacI diges- <br />                                                                                                    tion integrant concatenated plasmids yields                                                                                                    13.2-kb fragment. (D) Schematic falcipain-2 knockout <br />                                                                                                                                                                        MICROBIOLOGY <br />  <br />  <br />                                                                                                    resulting single crossover. integration results                                                                                                    promoter copy falcipain-2, indicated FP2*. PacI <br />                                                                                                    digestion integrant concatenated plasmids <br />                                                                                                    results 26-kb fragment. (E) Southern blot PacI digested <br />                                                                                                    total DNA untransfected parasites (WT), falcipain-2 sin- <br />                                                                                                    gle knockout clones (FP2a, FP2b, FP2c, FP2d), plas- <br />                                                                                                    mepsins IV, falcipain-2 triple knockout clones (Triple <br />                                                                                                    1 Triple 2). Wt-FP2 indicates fragment corresponding <br />                                                                                                    WT falcipain-2 locus, d-K&#229;&#8230;&#190;O indicates falcipain-2 <br />                                                                                                    knockout resulting double crossover, s-K&#229;&#8230;&#190;O indicates <br />                                                                                                    falcipain-2 knockout resulting single crossover. <br />                                                                                                    FP2&#226;&#8364;&#8220;5&#226;&#172;&#732; used Southern probe. Falcipain-2&#226;&#172;&#732;, al- <br />                                                                                                    identical copy falcipain-2 expressed later                                                                                                    life cycle (11), cross-hybridizes probe. DNA size lad- <br />                                                                                                    ders  kb) shown right blots. <br />  <br />  <br /> Liu et al.                                                                                                  PNAS &#229;&#8230;&#169; June 6, 2006 &#229;&#8230;&#169; vol. 103 &#229;&#8230;&#169;  23 &#229;&#8230;&#169; 8841 <br />  seen going level higher RPMI <br /> medium 1640 (1,475 &#226;?&#174;M; data shown). chose 147.5 &#226;?&#174;M standard concentration AA supplemented isoleucine sole amino acid  medium). able culture P. falciparum clone 3D7 continuously &#226;&#172;&#381;2 months medium. data suggest P. falciparum use <br /> hemoglobin degradation main amino acid source. isoleucine absent human hemoglobin, parasite auxotrophic amino acid. support notion, <br /> parasite growth completely blocked 100 &#226;?&#174;M 4-thiaiso- <br /> leucine (Fig. 1C), blockade overcome high <br /> exogenous isoleucine concentrations (data shown). <br />  <br /> Growth Hemoglobin Degradation Enzyme Gene Knockout Lines Medium. Previous studies shown individual knock- <br /> outs food vacuole plasmepsins falci- <br /> pain-2 nearly normal growth phenotypes RPMI  <br /> dium 1640 (5, 16, 17). plasmepsin IV&#229;&#8230;&#190;I double knockout doubling time &#226;&#172;&#8225;10% longer parental strain; phenotype accentuated slightly 5AA (5). constructed triple knockout disrupting falcipain-2 plasmepsin <br /> IV&#229;&#8230;&#190;I double knockout background. comparison, sim- <br /> ilarly disrupted falcipain-2 WT background. Southern <br /> blots (Fig. 2) revealed single-crossover recombination correct locus  Additionally, double-crossover recom- <br /> bination clones single falcipain-2 knockout. triple knockout clones [plasmepsins I&#229;&#8230;&#190;IV falcipain-2 <br /> triple knockout clone 1 (Triple1) plasmepsins I&#229;&#8230;&#190;IV falcipain-2 triple knockout clone 2 (Triple2)] falcipain-2 single double crossover knockout clones <br /> (FP2b FP2c, respectively) chosen analysis. <br /> RT-PCR analysis  ref. 17) confirmed falcipain-2 <br /> disruption (data shown). falcipain-2 knockout <br /> lines (including triple knockout) displayed transient <br /> swollen food vacuole phenotype, reported single              Fig. 3. Growth knockout clones RPMI medium 1640 (Lower) falcipain-2 knockout (17). Knockout clones parental           medium (Upper). Parasitemias asynchronous cultures measured lines grown RPMI medium 1640 medium.                   flow cytometry. Fold increases parasites calculated graphed <br /> RPMI medium 1640, falcipain-2 knockout clones                 time. Black diamonds indicate WT; blue diamonds indicate plasmepsin <br />                                                                         IV&#229;&#8230;&#190;I double knockout; red triangles indicate falcipain-2 single knockout clone <br /> slightly slower-growing WT parental line,                                                                         b; green inverse triangles indicate falcipain-2 single knockout clone c; purple <br /> double plasmepsin knockout triple knockouts                 triangles indicate Triple 1; yellow inverse triangles indicate Triple 2. Error bars <br /> 12&#226;&#8364;&#8220;14% slower doubling times WT parental line (Fig.            indicate SD triplicate measurements. Curves simulated expo- <br /> 3 Table 1). contrast, growth knockout lines           nential growth model. colors symbols used curves. <br /> substantially impaired medium. Falcipain-2 knockouts           Doubling times calculated listed Table 1. <br /> 20% longer doubling times WT 4-fold <br /> fewer parasites end 7-day growth period. plasmepsin double knockout grew 28% slower WT                      slightly sensitive, seen (5). Falcipain-2 <br /> (5-fold fewer parasites). triple knockout grew 41%             knockout clones &#226;&#172;&#8225;30-fold sensitive, slower doubling time WT (10-fold fewer parasites).                 reported (17). Triple knockout parasites comparable Despite  culture maintained slow exponential               sensitivity falcipain-2 single knockouts. parasites growth 3 weeks. data suggest things.         substantially sensitive pepstatin grown parasites grow better degrade hemoglobin             medium. WT, falcipain-2, plasmepsin IV&#229;&#8230;&#190;I knockouts rich medium. Second, parasites grown                3- 5-fold sensitive medium, suggesting parasites <br /> minimal medium, relying hemoglobin amino acid                  relying hemoglobin degradation primary amino acid <br /> source, falcipains plasmepsins important            source need plasmepsin activity optimal growth. process overlapping functions.                                 important components plasmepsin falcipain families <br />                                                                         deleted (triple knockouts), growth medium ex- <br /> Sensitivity Protease Inhibitors Medium. assess   quisitely sensitive pepstatin  IC50 values nano- <br /> interrelationship families hemoglobin-degrading           molar range, hundreds fold values determined proteases, treated knockout parasites cysteine              RPMI medium 1640. heightened sensitivity compared protease inhibitor trans-epoxysuccinyl- L -leucylamino(4-               falcipain-2 single knockout explained fact guanidine)-butane (E64) (Fig. 4A) aspartic protease              plasmepsins IV food vacuole plasmepsins inhibitor pepstatin (Fig. 4B). Growth parasite lines       order magnitude sensitive pepstatin slightly sensitive E64 medium RPMI medium          (9). knocked  remaining plas- <br /> 1640 (Fig. 4A, linear concentration scale, Table 2).           mepsins easily inhibited. data suggest blocking <br /> dramatic differences seen parasites grown pepstatin        plasmepsins falcipain-2 food vacuole forces (Fig. 4B, logarithmic concentration scale, Table 2).           reliance exogenous amino acids survival. Growth slowed <br /> RPMI medium 1640, WT parasites poorly sensitive                 parasites impaired hemoglobin degradation pepstatin plasmepsin double knockout parasites               RPMI medium 1640  Fig. 4) halted medium.  <br /> 8842 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0601876103                                                                                               Liu et al. <br />  Table 1. Doubling times (T) calculated simulation                            Table 2. Estimated IC50 values inhibition curves Fig. 4 <br /> curves Fig. 3                                                                                      Pepstatin  IC50, &#226;?&#174;M                 E64, IC50, &#226;?&#174;M <br />                            medium                       RPMI medium 1640 <br /> Parasite                                                                              Parasite        RPMI                            RPMI               clone               T, h           % WT               T, h           % WT       clone        medium 1640         medium        medium 1640        medium <br />  <br /> WT                  16.4              100               14.6               100        WT                 60              31                4.4              2.8 <br /> PM4&#229;&#8230;&#190;1               21.0              128               16.3               112        PM 4&#229;&#8230;&#190;1             70              22                3.6              2.1 <br /> FP2b                20.2              123               15.6               107        FP2b               2.3              0.5              1.8              1.3 <br /> FP2c                19.3              118               15.6               108        FP2c               3.3              0.6              2.0              1.2 <br /> Triple 1            23.2              141               16.5               113        Triple 1           2.1             &#226;&#172;?0.2              2.1              0.8 <br /> Triple 2            23.2              141               16.7               114        Triple 2           2.1             &#226;&#172;?0.1              1.9              0.8 <br />  <br />    PM4&#229;&#8230;&#190;1, plasmepsin I&#229;&#8230;&#190;IV double knockout; FP2b, falcipain-2 single knockout             PM4&#229;&#8230;&#190;1, plasmepsin I&#229;&#8230;&#190;IV double knockout; FP2b, falcipain-2 single knockout <br /> clone b; FP2c, falcipain-2 single knockout clone c.                                   clone b; FP2c, falcipain-2 single knockout clone c. <br />  <br />  <br />  <br /> flip falcipain axis fully operational (WT                    biochem). IC50 value RPMI medium 1640-cultured 3D7 plasmepsin double knockout) blockade plasmepsins                        parasites old pepstatin (7 &#226;?&#174;M) line published small effect parasites, organism relying                   reports (5, 15, 17), IC50 new preparations hemoglobin degradation amino acid supply  medium).                           higher (&#226;&#172;&#8225;60 &#226;?&#174;M; Table 2). Inhibition curves various <br />                                                                                       knockout clones quite similar old pepstatin (Fig. 5, <br /> Pepstatin  noted discrepancy potency                            published supporting information PNAS web <br /> 5-year-old pepstatin  Streptomyces sp., Sigma) fresh                       site) new, synthetic pepstatin (Fig. 4B) shifted order <br /> pepstatin  Streptomyces sp., Sigma) synthetic (Cal-                         magnitude. chose present data using new <br />                                                                                       pepstatin better-defined reagent (chemically <br />                                                                                       synthesized <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-5' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span>peptide</span> compared partially purified microbial <br />                                                                                       extract). Analysis preparations liquid chromatogra- <br />                                                                                       phy&#229;&#8230;&#190;MS (Fig. 6, published supporting information                                                                                       PNAS web site) revealed dominant component, <br />                                                                                       identified pepstatin MS. number                                                                                       contaminants old pepstatin preparation. newer Sigma <br />                                                                                       pepstatin contained fewer contaminants (data shown)                                                                                       potency similar synthetic version. Titration pep- <br />                                                                                       statin protease inhibitory activity plasmepsin II enzyme <br />                                                                                       (Fig. 7, published supporting information                                                                                       PNAS web site) revealed superimposable quantities aspartic <br />                                                                                       protease-inhibitory activity old synthetic pepstatin                                                                                       preparations. conclude likely contam- <br />                                                                                       inant old pepstatin increased potency. <br />  <br />                                                                                       Discussion <br />                                                                                       P. falciparum grow culture                                                                                       isoleucine sole exogenous amino acid. Previous studies, <br />                                                                                       rich RPMI medium 1640, suggested parasite <br />                                                                                       excretes amino acids hemoglobin degradation <br />                                                                                       hemoglobin degradation minimal im- <br />                                                                                       portance amino acid source organism (6).                                                                                       contrast, force parasites rely hemoglobin degra- <br />                                                                                       dation,  need isoleucine sup- <br />                                                                                       plementation absent human hemoglobin).                                                                                       finding physiologically relevant                                                                                       children malaria endemic regions malnourished                                                                                       contain low, undetectable, levels plasma amino acids (19, <br />                                                                                       20).  RPMI medium 1640 higher concentration                                                                                                                                                                      MICROBIOLOGY <br />  <br />  <br />  <br />                                                                                       amino acids  20 times) normal plasma (21, 22). <br />                                                                                          studies P. falciparum strain 3D7,                                                                                       parental background knockouts. Fig. 4. Sensitivities protease inhibitors.   E64 sensitivities. Parasites   tested number isolates addition incubated E64 62 h. percent growth cultures compared             isoleucine strains need methionine supplementation untreated culture graphed E64 concentration linear scale.           optimal growth (unpublished results). Methionine present Solid diamonds solid lines indicate medium; open diamonds dotted            low (1%) levels human hemoglobin, endogenous <br /> lines indicate RPMI medium 1640. Error bars indicate SD triplicate             supply borderline adequate. Seven-day growth 3D7 measurements. PM4&#229;&#8230;&#190;1, plasmepsin I&#229;&#8230;&#190;IV double knockout; FP2b, falcipain-2 <br />                                                                                       better medium 5AA (5), isoleucine <br /> single knockout clone b; FP2c, falcipain-2 single knockout clone c. (B) Pepstatin sensitivities. Parasites incubated pepstatin 63 h. percent <br />                                                                                       concentration identical. understand reason growth cultures compared untreated culture graphed             difference, appears unlikely simple <br /> pepstatin concentration log10 scale. Symbols lines        competition uptake isoleucine, increasing  E64 pepstatin IC50 values listed Table 2.                             isoleucine 5AA does improve growth (data shown). <br />  <br /> Liu et al.                                                                                                     PNAS &#229;&#8230;&#169; June 6, 2006 &#229;&#8230;&#169; vol. 103 &#229;&#8230;&#169;  23 &#229;&#8230;&#169; 8843 <br />  complex cotransport countertrans-             <span id='am-13' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-14' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="CO2" datatype="xsd:string"></span>CO2</span>, 5% <span id='am-47' about='obo:IMR_0200217' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-48' property="rdfs:label" content="O2" datatype="xsd:string"></span><span id='am-49' property="oboInOwl:id" content="IMR:0200217" datatype="xsd:string"></span><span id='am-50' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasDbXref" content="KEGG:C00007" datatype="xsd:string"></span>O2</span>, 90% N2. RPMI medium 1640 standard <br /> port phenomenon interesting study.                      RPMI medium 1640 (Invitrogen) containing 20 amino acids    knockout inhibitor studies clearly parasites        supplemented 27 mM NaHCO3, 22 mM glucose, 0.37 mM impaired hemoglobin degradation machinery grow better            <span id='am-37' about='obo:IMR_0200173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-38' property="rdfs:label" content="Hypoxanthine" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="KEGG:C00262" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:id" content="IMR:0200173" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>hypoxanthine</span>, 10 &#226;?&#174;g&#229;&#8230;&#190;ml gentamicin, 5 g&#229;&#8230;&#190;liter Albumax   RPMI medium 1640 medium.  provision             vitrogen). RPMI medium 1640 lacking amino acids  AA) exogenous amino acids overcome slowed hemoglobin                  custom tissue culture center Washington <br /> degradation. hemoglobin degradation drastically attenu-            University School Medicine. Single amino acids (isoleucine, <br /> ated,  falcipain-2 knockout parasites treated         glutamine, glutamate, methionine, cysteine; Sigma) pepstatin  RPMI medium 1640                 added concentrations RPMI medium 1640 make <br /> promote growth. hemoglobin degradation neces-                5AA. Isoleucine added 147.5 &#226;?&#174;M make medium. <br /> sary survival independent amino acid generation.              Supplements added RPMI medium 1640  example, protease classes overlapping func-           medium supplemented dialyzed Albumax gave similar results <br /> tion process egress osmotic regulation.            undialyzed Albumax. <br /> Alternatively, nutrient parasite derives hemoglobin accessed medium.                 Disruption Falcipain-2 Gene. fragments falcipain-2 <br /> Plasmodium <span id='am-42' about='obo:IMR_0200435' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-43' property="oboInOwl:id" content="IMR:0200435" datatype="xsd:string"></span><span id='am-44' property="rdfs:label" content="Iron" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:hasDbXref" content="KEGG:C00023" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>iron</span> acquisition poorly understood,           gene amplified genomic DNA using primers heme hemoglobin sequestered                   GGTTAAGCTTATGGATTACAACATGG GGTTA- <br /> parasite hemozoin, possible parasite relies         AGCTTGTTATGCATATTTACTTTG 5&#226;&#172;&#732; fragment (590 <br /> release small iron metabolism (23).            bp, called FP2&#226;&#8364;&#8220;5&#226;&#172;&#732;) CCTGAATTCGGATCTTGCTGGGC- <br /> amino acid conceivably inaccessible               CTTTAG GGTGAATTCTTAGGCAATTAATGGATG <br /> external medium.                                                         3&#226;&#172;&#732; fragment (605 bp, called FP2&#226;&#8364;&#8220;3&#226;&#172;&#732;). FP2&#226;&#8364;&#8220;5&#226;&#172;&#732; FP2&#226;&#8364;&#8220;3&#226;&#172;&#732; <br />    Amino acid acquisition clearly important process        sequenced cloned knockout vector, malaria parasite, reflected multiple layers redun-        modified version pHC1 (26). modified vector, select- <br /> dancy. ability use exogenous (RPMI medium 1640)                able marker BSD (27) driven PcDT promoter element. endogenous (hemoglobin) amino acids primary source           single gene falcipain-2 knockout, parental 3D7 culture (WT) <br /> layer, described  presence multiple plasmepsins          transfected plasmid described (5) grown overlapping specificity function (5, 9) multiple            presence 3.5 &#226;?&#174;g&#229;&#8230;&#190;ml blasticidin 2 weeks. culture falcipains overlap (24) layer. final      subjected drug cycle (21-day growth drug, followed <br /> layer, gained insight, redundancy         reselection blasticidin parasites reappeared). falcipain plasmepsin families. Knockout               triple knockout plasmepsins IV, falcipain-2, plasmep- <br /> falcipain-2 minimal effect parasite growth rich <br />                                                                          sin knockout clone PMIV&#229;&#8230;&#190;I A5 (5) transfected medium (ref. 17 work) significant,                                                                          falcipain-2 knockout vector cycled twice. Parasites cloned <br /> lethal, effect medium (4-fold growth defect 1 week). <br />                                                                          method limiting dilution. Vector integration analyzed <br /> Knockout individual plasmepsins gives similar results (5). <br />                                                                          Southern blot described (5). <br /> Knockout components families combination nearly additive, suggesting overlap function families. <br />                                                                          Flow Cytometry. P. falciparum cultures stained 0.5 results suggest gene duplication enzymes                                                                          &#226;?&#174;g&#229;&#8230;&#190;ml acridine orange (Molecular Probes) PBS used selected provide increased protease dosage sophisticated complementary cleavage               1 h. total 3 &#226;&#171;&#187; 104 cells sample counted specificities. noted current study,        BD Biosciences Canto flow cytometer. FITC channel <br /> selected gene knockouts produced. possible         detector records green fluorescence acridine orange plasmepsin falcipain knockouts combination           binds DNA (maximum emission 525 nm), crucial parasite growth. study required.                  phycoerythrin (PE) channel detector records red fluores- <br />    Pepstatin treatment minimal effect WT parasites            cence acridine orange binds RNA (maximum high concentrations killed falcipain-2 knockout       emission 650 nm). channels distinguish parasite- <br /> clones potently. effects dramatic medium,        infected RBC uninfected RBC based DNA triple knockout, low nanomolar concentrations killed          RNA content differences. Forward size scattering (FSC) parasites. fact pepstatin kills parasites impaired         used count total cell number. channels, <br /> hemoglobin degradation, especially forced rely       peak height signals (FITC-H, PE-H, FSC-H) used hemoglobin amino acid source, strongly suggests pep-          analysis F LOWJO software (Treestar, Ashland, . Para- <br /> statin able food vacuole block aspartic         sitemia gates defined population cells having <br /> protease function. long suspected pepstatin got       intense signals FITC-H PE-H channels distinct cells poorly, accounting low potency cultured       main body cells (uninfected RBCs). Gating parasites.  data suggest pepstatin effective    parasite populations verified blood smears. WT parasites blockade plasmepsins lethal.           experiment Fig. 4, culture fixed 0.05% glutaraldehyde <br /> Dozens laboratories hundreds compounds targeted          PBS stored 4&#194;&#176;C. cells permeabilized plasmepsins (25). potent pepstatin        0.25% Triton X-100 PBS 5 min room temperature isolated enzyme, limited efficacy cultured parasites.    stained 0.5 &#226;?&#174;g&#229;&#8230;&#190;ml acridine orange use. Parasite  bioavailability thought limitation,      growth rate calculated reported (5). <br /> current data suggest bioefficacy problem. Food <br /> vacuole plasmepsin inhibition does appear promising          Inhibition Assay. Asynchronous cultures starting parasitemia <br /> strategy antimalarial drug development, unless combined         1&#226;&#8364;&#8220;1.5% incubated varying amounts E64 <br /> falcipain inhibition.                                                    (Sigma) synthetic pepstatin (Calbiochem)                                                                          inhibitor (control culture) 62 63 h medium <br /> Materials Methods                                                    indicated. Parasitemias counted f low cytometry, Parasite Culture. P. falciparum strain 3D7 derived knockout          increase parasitemia (relative control culture set lines cultured described (5). Briefly, asexual-stage parasites   100%) graphed inhibitor concentration. grown human O&#226;&#171;&#185; erythrocytes 2% hematocrit 5%            series experiments, culture incubated  <br /> 8844 &#229;&#8230;&#169; www.pnas.org&#229;&#8230;&#190;cgi&#229;&#8230;&#190;doi&#229;&#8230;&#190;10.1073&#229;&#8230;&#190;pnas.0601876103                                                                                  Liu et al. <br />  4-thiaisoleucine (Sigma) times indicated analyzed                              study supported National Institutes Health Grant                                                                                   AI47798. <br />  <br />  <br />  1. Loria, P., Miller, S., Foley, M. <span id='am-6' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="AMP" datatype="xsd:string"></span>amp</span>; Tilley, L. (1999) Biochem. J. 339, 363&#226;&#8364;&#8220;370.         15. Bailly, E., Jambou, R., Savel, J. &amp; Jaureguiberry, G. (1992) J. Protozool. 39, <br />  2. Goldberg, D. E. (2005) Malaria: Drugs, Disease, Post-Genomic Biology,               593&#226;&#8364;&#8220;599. <br />     eds. Sullivan, D. &amp; Krishna, S. (Springer, Berlin), pp. 275&#226;&#8364;&#8220;291.                       16. Omara-Opyene,  L., Moura, P. , Sulsona, C. R., Bonilla, J. , Yowell, <br />  3. Sherman,  W. (1977) Bull. W. H. O. 55, 265&#226;&#8364;&#8220;276.                                          C. , Fujioka, H., Fidock, D.  &amp; Dame, J. B. (2004) J. Biol. Chem. 279, <br />  4. Divo,  , Geary, T. G., Davis, N. L. &amp; Jensen, J. B. (1985) J. Protozool. 32,           54088&#226;&#8364;&#8220;54096. <br />     59&#226;&#8364;&#8220;64.                                                                                 17. Sijwali, P. S. &amp; Rosenthal, P. J. (2004) Proc. Natl. Acad. Sci. USA 101, <br />  5. Liu, J., Gluzman,  Y., Drew, M. E. &amp; Goldberg, D. E. (2005) J. Biol. Chem.               4384&#226;&#8364;&#8220;4389. <br />     280, 1432&#226;&#8364;&#8220;1437.                                                                        18. Payne, S. H. &amp; Loomis, W. F. (2006) Eukaryot. Cell 5, 272&#226;&#8364;&#8220;276. <br />  6. Krugliak, M., Zhang, J. &amp; Ginsburg, H. (2002) Mol. Biochem. Parasitol. 119,            19. Whitehead, R. G. &amp; Dean, R. F. (1964)  J. Clin. Nutr. 14, 313&#226;&#8364;&#8220;319. <br />     249&#226;&#8364;&#8220;256.                                                                               20. Baertl, J. M., Placko, R. P. &amp; Graham, G. G. (1974)  J. Clin. Nutr. 27, <br />  7. Lew, V. L., Tiffert, T. &amp; Ginsburg, H. (2003) Blood 101, 4189&#226;&#8364;&#8220;4194.                        733&#226;&#8364;&#8220;742. <br />  8. Allen, R. J. &amp; Kirk, K. (2004) Trends Parasitol. 20, 7&#226;&#8364;&#8220;10. <br />                                                                                            21. Aguilo, , Castano, E., Tauler, P., Guix, M. P., Serra, N. &amp; Pons,  (2000) <br />  9. Banerjee, R., Liu, J., Beatty, W., Pelosof, L., Klemba, M. &amp; Goldberg, D. E. <br />                                                                                                J. Nutr. Biochem. 11, 81&#226;&#8364;&#8220;86. <br />     (2002) Proc. Natl. Acad. Sci. USA 99, 990&#226;&#8364;&#8220;995. <br />                                                                                            22. Jones, D. P., Carlson, J. L., Mody, V. C., Cai, J., Lynn, M. J. &amp; Sternberg, P. <br /> 10. Shenai, B. R., Sijwali, P. S., Singh,  &amp; Rosenthal, P. J. (2000) J. Biol. Chem. <br />                                                                                                (2000) Free Radical Biol. Med. 28, 625&#226;&#8364;&#8220;635. <br />     275, 29000&#226;&#8364;&#8220;29010. <br /> 11. Singh, N., Sijwali, P. S., Pandey, K. C. &amp; Rosenthal, P. J. (2006) Exp. Parasitol.     23. Loyevsky, M. &amp; Gordeuk, V. R. (2001) Antimalarial Chemotherapy, Mech- <br />     112, 187&#226;&#8364;&#8220;192.                                                                              anism Action, Resistance, New Directions Drug Discovery, ed. <br /> 12. Sijwali, P. S., Shenai, B. R., Gut, J., Singh,  &amp; Rosenthal, P. J. (2001) Biochem.       Rosenthal, P. J. (Humana, Totowa, NJ), pp. 307&#226;&#8364;&#8220;324. <br />     J. 360, 481&#226;&#8364;&#8220;489.                                                                       24. Dahl, E. L. &amp; Rosenthal, P. J. (2005) Mol. Biochem. Parasitol. 139, 205&#226;&#8364;&#8220;212. <br /> 13. Banerjee, R. &amp; Goldberg, D. E. (2001) Antimalarial Chemotherapy, Mech-              25. Boss, C., Richard-Bildstein, S., Weller, T., Fischli, W., Meyer, S. &amp; Binkert, C. <br />     anism Action, Resistance, New Directions Drug Discovery, ed.                     (2003) Curr. Med. Chem. 10, 883&#226;&#8364;&#8220;907. <br />     Rosenthal, P. J. (Humana, Totowa, NJ), pp. 43&#226;&#8364;&#8220;63.                                      26. Crabb, B. S., Triglia, T., Waterkeyn, J. G. &amp; Cowman,  F. (1997) Mol. <br /> 14. Rosenthal, P. J. (2001) Antimalarial Chemotherapy, Mechanisms Action,                Biochem. Parasitol. 90, 131&#226;&#8364;&#8220;144. <br />     Resistance, New Directions Drug Discovery, ed. Rosenthal, P. J. (Humana,        27. Mamoun, C. B., Gluzman,  Y., Goyard, S., Beverley, S. M. &amp; Goldberg, D. E. <br />     Totowa, NJ), pp. 325&#226;&#8364;&#8220;345.                                                                  (1999) Proc. Natl. Acad. Sci. USA 96, 8716&#226;&#8364;&#8220;8720. <br />  <br />  <br />  <br />  <br />                                                                                                                           <br /> </body></html>